Pharmaceutical giant GSK has opened a new facility at its Barnard Castle site after a £90m investment.
The aseptic smart manufacturing facility - known as Q Block - will allow the Barnard Castle site to strengthen its global role in bringing new medicines for a range of diseases into production, GSK said.
Trials of the fully automated facility, which uses digital technology to make manufacturing operations as efficient as possible, began in 2020 and it will start manufacturing medicines for commercial use during the first half next year.